4'-Bromo-4-methylaminorex (4B-MAR, 4'-Br-4-MAR) is a designer drug from the substituted aminorex family, first definitively identified in Austria in January 2022. Its pharmacological activity has not been reported, but it is believed to have stimulant effects.[1]
Identifiers | |
---|---|
| |
CAS Number |
|
PubChem CID | |
Chemical and physical data | |
Formula | C10H11BrN2O |
Molar mass | 255.115 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
editReferences
edit- ^ Seibert E, Kunert O, Pferschy-Wenzig EM, Schmid MG (September 2022). "Characterization of Three Novel 4-Methylaminorex Derivatives Applied as Designer Drugs". Molecules. 27 (18). Basel, Switzerland: 5770. doi:10.3390/molecules27185770. PMC 9503756. PMID 36144500.